Role of altered sialylation of the i-like domain of β1 integrin in the binding of fibronectin to β1 integrin: Thermodynamics and conformational analyses

Biophysical Journal

Volumn 99, Issue 1, 2010, Pages 208-217

  Pan, Di ^a   Song, Yuhua ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYL-GLYCYL-ASPARTIC ACID; BETA1 INTEGRIN; FIBRONECTIN; OLIGOPEPTIDE; POLYSACCHARIDE; PROTEIN BINDING;

CHEMISTRY; GLYCOSYLATION; METABOLISM; MOLECULAR DYNAMICS; MOVEMENT (PHYSIOLOGY); PROTEIN TERTIARY STRUCTURE; THERMODYNAMICS;

ANTIGENS, CD29; FIBRONECTINS; GLYCOSYLATION; MOLECULAR DYNAMICS SIMULATION; MOVEMENT; OLIGOPEPTIDES; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; THERMODYNAMICS;

EID: 77954377943     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.03.063     Document Type: Article

References (54)

1. Humphries, M. J., M. A. Travis, A. P. Mould. 2004. Mechanisms of integration of cells and extracellular matrices by integrins. Biochem. Soc. Trans. 32: 822-825.
2. George, E. L., E. N. Georges-Labouesse, R. O. Hynes. 1993. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 119: 1079-1091.
3. Plopper, G. E., S. Z. Domanico, V. Quaranta. 1998. Migration of breast epithelial cells on Laminin-5: differential role of integrins in normal and transformed cell types. Breast Cancer Res. Treat. 51: 57-69.
4. Melchiori, A., R. Mortarini, A. Albini. 1995. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. Exp. Cell Res. 219: 233-242.
5. Weber, C. 2003. Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J. Mol. Med. 81: 4-19.
6. Shimizu, Y., D. M. Rose, and M. H. Ginsberg. 1999. Integrins in the immune system. Adv. Immunol. 72: 325-380.
7. Isaji, T., Y. Sato, J. Gu. 2009. N-glycosylation of the I-like domain of beta1 integrin is essential for beta1 integrin expression and biological function: identification of the minimal N-glycosylation requirement for alpha5beta1. J. Biol. Chem. 284: 12207-12216.
8. Isaji, T., Y. Sato, J. Gu. 2006. N-glycosylation of the beta-propeller domain of the integrin alpha5 subunit is essential for alpha5beta1 heterodimerization, expression on the cell surface, and its biological function. J. Biol. Chem. 281: 33258-33267.
9. Gu, J., and N. Taniguchi. 2004. Regulation of integrin functions by N-glycans. Glycoconj. J. 21: 9-15.
10. Bellis, S. L. 2004. Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins. Biochim. Biophys. Acta. 1663: 52-60.
11. Semel, A. C., E. C. Seales, S. L. Bellis. 2002. Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. J. Biol. Chem. 277: 32830-32836.
12. Sato, Y., T. Isaji, J. Gu. 2009. An N-glycosylation site on the betapropeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N- acetylglucosaminyltransferase III. J. Biol. Chem. 284: 11873-11881.
13. Seales, E. C., F. M. Shaikh, S. L. Bellis. 2005. A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering betal integrin sialylation. J. Biol. Chem. 280: 37610-37615.
14. Lee, J. O., L. A. Bankston, R. C. Liddington. 1995. Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure. 3: 1333-1340.
15. Takagi, J., D. P. DeBottis, T. A. Springer. 2002. The role of the specificity-determining loop of the integrin beta subunit I-like domain in autonomous expression, association with the alpha subunit, and ligand binding. Biochemistry. 41: 4339-4347.
16. Humphries, M. J. 2000. Integrin structure. Biochem. Soc. Trans. 28: 311-339.
17. Xiong, J. P., T. Stehle, M. A. Arnaout. 2001. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science. 294: 339-345.
18. Barton, S. J., M. A. Travis, A. P. Mould. 2004. Novel activating and inactivating mutations in the integrin beta1 subunit A domain. Biochem. J. 380: 401-407.
19. Puzon-McLaughlin, W., and Y. Takada. 1996. Critical residues for ligand binding in an I. domain-like structure of the integrin beta1 subunit. J. Biol. Chem. 271: 20438-20443.
20. Liu, Y., D. Pan, Y. Song. 2008. Effect of altered glycosylation on the structure of the I-like domain of beta1 integrin: a molecular dynamics study. Proteins. 73: 989-1000.
21. Pankov, R., and K. M. Yamada. 2002. Fibronectin at a glance. J. Cell Sci. 115: 3861-3863.
22. Plow, E. F., T. A. Haas, J. W. Smith. 2000. Ligand binding to integrins. J. Biol. Chem. 275: 21785-21788.
23. Grant, R. P., C. Spitzfaden, H. J. Mardon. 1997. Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin. J. Biol. Chem. 272: 6159-6166.
24. Baron, M., A. L. Main, I. D. Campbell. 1992. 1H NMR assignment and secondary structure of the cell adhesion type III module of fibronectin. Biochemistry. 31: 2068-2073.
25. Corbett, S. A., and J. E. Schwarzbauer. 1999. Requirements for alpha(5)beta(1) integrin-mediated retraction of fibronectin-fibrin matrices. J. Biol. Chem. 274: 20943-20948.
26. Danen, E. H., S. Aota, G. N. van Muijen. 1995. Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta 1. J. Biol. Chem. 270: 21612-21618.
27. Sechler, J. L., S. A. Corbett, and J. E. Schwarzbauer. 1997. Modulatory roles for integrin activation and the synergy site of fibronectin during matrix assembly. Mol. Biol. Cell. 8: 2563-2573.
28. Leahy, D. J., I. Aukhil, and H. P. Erickson. 1996. 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell. 84: 155-164.
29. Kirschner, K. N., A. B. Yongye, R. J. Woods. 2008. GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J. Comput. Chem. 29: 622-655.
30. Okur, A., L. Wickstrom, C. Simmerling. 2006. Improved efficiency of replica exchange simulations through use of a hybrid explicit/implicit solvation model. J. Chem. Theory Comput. 2: 420-433.
31. Martí-Renom, M. A., A. C. Stuart, A. Sali. 2000. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29: 291-325.
32. Laskowski, R. A., M. W. MacArthur, J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26: 283-291.
33. Colovos, C., and T. O. Yeates. 1993. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 2: 1511-1519.
34. Hooft, R. W., G. Vriend, E. E. Abola. 1996. Errors in protein structures. Nature. 381:272.
35. Puklin-Faucher, E., M. Gao, V. Vogel. 2006. How the headpiece hinge angle is opened: new insights into the dynamics of integrin activation. J. Cell Biol. 175: 349-360.
36. Humphrey, W., A. Dalke, and K. Schulten, 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14: 33-38, 27-38.
37. Imberty, A., and S. Pérez. 2000. Structure, conformation, and dynamics of bioactive oligosaccharides: theoretical approaches and experimental validations. Chem. Rev. 100: 4567-4588.
38. Takagi, J., and T. A. Springer. 2002. Integrin activation and structural rearrangement. Immunol. Rev. 186: 141-163.
39. Takagi, J., B. M. Petre, T. A. Springer. 2002. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell. 110: 599-611.
40. Pierschbacher, M. D., and E. Ruoslahti. 1987. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J. Biol. Chem. 262: 17294-17298.
41. Scarborough, R. M., M. A. Naughton, I. F. Charo. 1993. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J. Biol. Chem. 268: 1066-1073.
42. Nowlin, D. M., F. Gorcsan, P. M. Cardarelli. 1993. A novel cyclic pentapeptide inhibits alpha 4 beta 1 and alpha 5 beta 1 integrin-mediated cell adhesion. J. Biol. Chem. 268: 20352-20359.
43. Beer, J. H., K. T. Springer, and B. S. Coller. 1992. Immobilized ArgGly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood. 79: 117-128.
44. Krammer, A., H. Lu, V. Vogel. 1999. Forced unfolding of the fibronectin type III module reveals a tensile molecular recognition switch. Proc. Natl. Acad. Sci. USA. 96: 1351-1356.
45. Gao, M., D. Craig, K. Schulten. 2002. Identifying unfolding intermediates of FN-III(10) by steered molecular dynamics. J. Mol. Biol. 323: 939-950. (Pubitemid 35341066)
46. García, A. J., M. D. Vega, and D. Boettiger. 1999. Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol. Biol. Cell. 10: 785-798.
47. Hamburger, Z. A., M. S. Brown, P. J. Bjorkman. 1999. Crystal structure of invasin: a bacterial integrin-binding protein. Science. 286: 291-295.
48. Redick, S. D., D. L. Settles, H. P. Erickson. 2000. Defining fibronectin's cell adhesion synergy site by site-directed mutagenesis. J. Cell Biol. 149: 521-527.
49. Krammer, A., D. Craig, V. Vogel. 2002. A structural model for force regulated integrin binding to fibronectin's RGD-synergy site. Matrix Biol. 21: 139-147.
50. Craig, D., A. Krammer, V. Vogel. 2001. Comparison of the early stages of forced unfolding for fibronectin type III modules. Proc. Natl. Acad. Sci. USA. 98: 5590-5595.
51. Lange, O. F., and H. Grubmuller. 2006. Can principal components yield a dimension reduced description of protein dynamics on long time scales? J. Phys. Chem. 110: 22842-22852.
52. Hayward, S., A. Kitao, N. Go. 1993. Effect of solvent on collective motions in globular protein. J. Mol. Biol. 234: 1207-1217.
53. Berendsen, H. J., and S. Hayward. 2000. Collective protein dynamics in relation to function. Curr. Opin. Struct. Biol. 10: 165-169.
54. Bradley, M. J., P. T. Chivers, and N. A. Baker. 2008. Molecular dynamics simulation of the Escherichia coli NikR protein: equilibrium conformational fluctuations reveal interdomain allosteric communication pathways. J. Mol. Biol. 378: 1155-1173.